FDA Article 3 Notice of ORA Program Alignment

On February 23, 2016, FDA provided formal notice to NTEU regarding a plan to implement a realignment of the current FDA/ORA structure through a Program Alignment initiative. According to the FDA, the proposed Program Alignment is a plan to modernize and strengthen the way FDA fulfills its public health and regulatory role, enabling it to keep up with scientific innovation, expanding global markets, and new mandates. The agency has indicated that the Program Alignment will not result in job loss, change in grade, change in duty station or office locations, and will have no adverse impact on the working conditions of bargaining unit employees.

Prior to receiving the formal notice, NTEU had an opportunity to provide predecisional input regarding the agency’s plan for the proposed realignment. During conversations with agency officials, NTEU raised numerous concerns regarding the impact of this realignment on employees, to include increased travel requirements, changes in duties that would require employees to specialize their work, and concerns regarding the fact that this model would essentially require employees to report to two supervisors. NTEU has made several information requests in order to obtain data and other information about the initiative that agency officials were unable to provide during predecisional discussions.

NTEU has invoked its right to bargain this initiative and has requested a briefing to learn more about the current status of the realignment and the agency’s plans for implementation. NTEU has also reminded the agency of its contractual and statutory duty to bargain prior to implementation.

NTEU National President Tony Reardon has appointed the following bargaining team members:

  • Cheryl Monroe (Chapter 230 President)
  • David Arvelo (Chapter 254 President)
  • Mike Theodorakis (Chapter 282 President)
  • Russell Glapion (Chapter 290 President)
  • Joe Teixeira (Chapter 288 President) as Alternate

The team will meet this week to draft proposals. NTEU plans to submit proposals and begin bargaining as soon as possible.

Your feedback is very important to me. I encourage you to share your opinion on this significant change in working conditions.

Author: chapterpresident

I have worked in the FDA since 1990 in a variety of positions. I currently serve as chapter president of NTEU Chapter 254, representing FDA employees in Arkansas, Colorado, Iowa, Kansas, Missouri, Nebraska, New Mexico, Oklahoma, Texas, and Utah.